CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: Rotigotine Restless Legs Syndrome Dose Finding Trial [Phase 2]
Summary
A Phase 2 dose-finding trial of rotigotine for idiopathic restless legs syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Idiopathic Restless Leg Syndrome | Phase 2 | Status: COMPLETED